Jyong Biotech Ltd. (MENS) vs PolyPid Ltd. (PYPD)

Jyong Biotech Ltd. and PolyPid Ltd. are both Biotechnology companies. Jyong Biotech Ltd. and PolyPid Ltd. are of similar size ($133.6M and $124.7M). Across the 4 metrics below, Jyong Biotech Ltd. leads on 2 and PolyPid Ltd. on 2.

Valuation

Metric MENS PYPD Biotechnology median
P/E — n/m 10.60
P/S — n/m 9.40
P/B n/m 25.80 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield — (24.10%) (32.88%)
Free cash flow yield — (55.32%) (23.13%)

Profitability

Metric MENS PYPD Biotechnology median
Gross margin — — 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (243.59%) (51.96%)
Return on assets — (119.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MENS PYPD Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (42.18%) 57.43% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MENS PYPD Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 0.45 1.35 4.97
Net debt to EBITDA (6.89) 0.39 1.01

Dividend

Metric MENS PYPD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MENS PYPD Biotechnology median
Market cap 133.62m 124.71m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack